Advisory Services Network’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
BG
WA
MC
RG
Advisory Services Network's ATRA Position: Q2 2023 in Review
Advisory Services Network sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 6 shares — an estimated $426 sold.
Advisory Services Network first reported a position in ATRA in Q4 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.
- Advisory Services Network reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
- Advisory Services Network sold 6 Atara Biotherapeutics shares in Q2 2023, an estimated $426.
- Advisory Services Network first reported a position in Atara Biotherapeutics in Q4 2020 and held it in 3 quarters.
- Advisory Services Network's Atara Biotherapeutics position peaked at $1K in Q4 2020.
- 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.
Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.